Clinical Evidence
Safety of EndoTool Versus Fixed-Dose Insulin Infusions for DKA or HHS in the Emergency Department
Objective
This retrospective study compares the safety of EndoTool glucose management software to a standard fixed-dose insulin infusion protocol for patients presenting to an emergency department with DKA or HHS.
Setting
433-bed not-for-profit acute care hospital.
Results
- Incidence of hypoglycemia <70 mg/dL was 0.00% of patients with EndoTool versus 4.7% with a standard fixed-dose insulin infusion protocol.
Conclusions
Titration of insulin using glucose management software (EndoTool) may be safer than a standard fixed-dose insulin infusion protocol for patients presenting in an emergency department with DKA or HHS, as evidenced by significantly lower incidence of hypoglycemia.
References
Authors
Meghin Moynihan, PharmD; Brandon Powell, PharmD, BCCCP; Ginger Barrick, PharmD, MSCR, BCPS; Kalynn Northam, PharmD, BCCCP.
Source
Presented at Society of Critical Care Medicine Critical Care Congress. Published in Critical Care Medicine, Volume 50, Issue 1, p605.
Year
2022
Related posts
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Clinical Evidence
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
EndoTool IV Leads to Over 55% Fewer Blood Glucose Checks With an 84% Decrease in Hypoglycemic Events at UPMC
Get in Touch
Ready to get started?
"*" indicates required fields